17357-74-3 Usage
Uses
Used in Organic Synthesis:
1-(5-Methyl-1H-pyrazol-3-yl)ethanone is used as a building block in organic synthesis for the creation of various heterocyclic compounds. Its versatile structure allows for the formation of complex molecules that are valuable in the development of new chemical entities.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(5-Methyl-1H-pyrazol-3-yl)ethanone is utilized as a key intermediate in the synthesis of potential drug candidates. Its unique reactivity and structural features make it a promising component in the design of novel therapeutic agents.
Used as a Ligand in Coordination Chemistry:
1-(5-Methyl-1H-pyrazol-3-yl)ethanone also serves as a ligand in coordination chemistry, where it can form complexes with metal ions. This application is crucial for the development of new materials with specific properties, such as catalysts or sensors, and contributes to the advancement of chemical research and technology.
Used in Drug Development:
Due to its potential applications in the development of new drugs and pharmaceuticals, 1-(5-Methyl-1H-pyrazol-3-yl)ethanone is employed in medicinal chemistry for the exploration of its biological activities and its integration into drug discovery processes. Its unique chemical properties may contribute to the creation of innovative therapeutic solutions.
Check Digit Verification of cas no
The CAS Registry Mumber 17357-74-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,3,5 and 7 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 17357-74:
(7*1)+(6*7)+(5*3)+(4*5)+(3*7)+(2*7)+(1*4)=123
123 % 10 = 3
So 17357-74-3 is a valid CAS Registry Number.
17357-74-3Relevant academic research and scientific papers
TRICYCLIC FUSED INDOLE DERIVATIVES AND THEIR USE AS AURORA KINASE INHIBITORS
-
Page/Page column 21-22, (2010/11/25)
Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them an
NOVEL PROCESSES
-
Page/Page column 12, (2008/06/13)
A novel intermediate compound of formula (II) wherein R1 is an oxygen protecting group can be use in an efficient process for making certain carbapenem compounds useful as anti-bacterial agents.
NOVEL PROCESSES
-
Page/Page column 8;13, (2010/02/12)
A novel process for preparing a compound of formula (E) comprising converting a compound of formula (J) to a compound of formula (E) using a Lewis acid, formula (J) and (E) wherein R2 is (C1-4)alkyl, (C1-3)alkoxy or phenyl optionally
NOVEL PROCESSES
-
Page/Page column 8;10, (2010/02/12)
The cyclization of compounds of formula (II) to carbapenem compounds of formula (III). wherein R1 is an oxygen protecting group, such as a silyl ether e.g. TBS and R is a readily removable carboxy protecting group, may be used in an improved process to prepare antibacterial compounds of formula (I).
